Atlas Trials

Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers

Clinical trial NCT06837077 · COMPLETED

Trial details

NCT number
NCT06837077
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypercholesterolemia and Hyperlipidemia
Start date
2025-03-14
Primary completion
2025-11-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.